March 29, 2023 — Scientists and regulators at the FDA have identified a critical gap in new drug development and labeling. It is the failure to test new drugs in people with obesity. Where there are differences in clinical responses and safety, labeling – the instructions for safe use – should reflect those differences. But in many cases, they […]
September 20, 2022 — Global food systems are putting more food – and more nutritious food – within within the reach of more people than ever before. But what are the outcomes for human and environmental health? For nutrition and equity? Frankly it’s a mixed picture. Food systems have evolved all over the world to crank out sufficient calories […]
May 12, 2022 — Somehow this doesn’t seem right. The list price for for a month’s supply of semaglutide when it’s for diabetes is $892. No matter whether you need a dose of 1 mg, or the new high dose of 2 mg, the price is the same. It goes under the brand name of Ozempic and comes from […]
April 23, 2022 — The buzzwords are flying. Diversity, equity, and inclusion is such a common theme that all you have to say is “DEI” and people will nod solemnly. The same goes for social determinants of health – SDOH. However, the Northeast Business Group on Health (NEBGH) has gone further to connect the two and identify some real […]
June 25, 2021 — In the realm of obesity and public health, the role of sugar-sweetened drinks in obesity is an article of faith. Questioning it will get you a tongue-lashing at best, but more likely, shunned. Likewise, the cool kids in public health expect you to agree that SSB taxes work. Yet again, we have a new study […]
